Entity Details

Primary name OPLA_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO14841
EntryNameOPLA_HUMAN
FullName5-oxoprolinase
TaxID9606
Evidenceevidence at protein level
Length1288
SequenceStatuscomplete
DateCreated1998-12-15
DateModified2021-06-02

Ontological Relatives

GenesOPLAH

GO terms

Show/Hide Table
GOName
GO:0005524 ATP binding
GO:0005829 cytosol
GO:0006749 glutathione metabolic process
GO:0006750 glutathione biosynthetic process
GO:0017168 5-oxoprolinase (ATP-hydrolyzing) activity
GO:0042802 identical protein binding

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR002821 Hydantoinase A/oxoprolinaseDomainDomain
IPR003692 Hydantoinase B/oxoprolinaseDomainDomain
IPR008040 Hydantoinaseoxoprolinase, N-terminalDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
260005 OMIM5-oxoprolinase deficiency (OPLAHD)A disorder characterized by calcium oxalate/carbonate urolithiasis, and excessive urinary 5-oxo-L-proline. Affected individuals have recurrent episodes of vomiting, diarrhea, and abdominal pain. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00142 Glutamic acidDrugbanksmall molecule

Interactions

6 interactions